Related references
Note: Only part of the references are listed.Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine
Kai Zhang et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
Intravenous arketamine for treatment-resistant depression: open-label pilot study
Gustavo C. Leal et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
Masaki Kato et al.
MOLECULAR PSYCHIATRY (2021)
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis
Anees Bahji et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
Adriana Feder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypes
Yaoyu Pu et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients
Xiaoyu Chen et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
Neural rhythm in the retrosplenial cortex during ketamine-induced dissociation
Kenji Hashimoto
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers
Torsten Passie et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research
Hartej Gill et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Plinio C. Casarotto et al.
CELL (2021)
Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study
Mu -Hong Chen et al.
GENOMICS (2021)
Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine
Steven F. Grieco et al.
TRANSLATIONAL PSYCHIATRY (2021)
Dextran sulfate sodium-induced inflammation and colitis in mice are ameliorated by (R)-ketamine, but not (S)-ketamine: A role of TrkB signaling
Yuko Fujita et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling
Yan Wei et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
Ketamine: A tale of two enantiomers
Luke A. Jelen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling
Youge Qu et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling
Atsuhiro Fujita et al.
PSYCHOPHARMACOLOGY (2020)
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
Fernanda S. Correia-Melo et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Antibiotic-induced microbiome depletion is associated with resilience in mice after chronic social defeat stress
Siming Wang et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review
David S. Mathai et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
Chadi G. Abdallah et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine: Role of BDNF-TrkB signaling
Yunfei Tan et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Neuronal brain injury after cerebral ischemic stroke is ameliorated after subsequent administration of (R)-ketamine, but not (S)-ketamine
Zhongwei Xiong et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
A historical review of antidepressant effects of ketamine and its enantiomers
Yan Wei et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
Kai Zhang et al.
TRANSLATIONAL PSYCHIATRY (2020)
d-glutamate and Gut Microbiota in Alzheimer's Disease
Chun-Hung Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice
Yunfei Tan et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Are NMDA and opioid receptors involved in the antidepressant actions of ketamine?
Kenji Hashimoto
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Brain control of humoral immune responses amenable to behavioural modulation
Xu Zhang et al.
NATURE (2020)
(2R,6R)-Hydroxynorketamine (HNK) plasma level predicts poor antidepressant response: is this the end of the HNK pipeline?
Chadi G. Abdallah
NEUROPSYCHOPHARMACOLOGY (2020)
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
Cristan A. Farmer et al.
NEUROPSYCHOPHARMACOLOGY (2020)
The spleen mediates chronic sleep restriction-mediated enhancement of LPS-induced neuroinflammation, cognitive deficits, and anxiety-like behavior
Dan Xu et al.
AGING-US (2020)
(S)-norketamine and (2S, 6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression
Rei Yokoyama et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
Kenji Hashimoto
BIOCHEMICAL PHARMACOLOGY (2020)
A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration
Jiancheng Zhang et al.
TRANSLATIONAL PSYCHIATRY (2020)
Neuregulin 1: an intriguing therapeutic target for neurodevelopmental disorders
Liang Shi et al.
TRANSLATIONAL PSYCHIATRY (2020)
Betaine supplementation is associated with the resilience in mice after chronic social defeat stress: a role of brain-gut-microbiota axis
Youge Qu et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Abnormal expression of colony stimulating factor 1 receptor (CSF1R) and transcription factor PU.1 (SPI1) in the spleen from patients with major psychiatric disorders: A role of brain-spleen axis
Jiancheng Zhang et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Association Between FoxO1, A2M, and TGF-β1, Environmental Factors, and Major Depressive Disorder
Mingzhe Zhao et al.
FRONTIERS IN PSYCHIATRY (2020)
Assessment of Ketamine and its Enantiomers in an Organophosphate-Based Rat Model for Features of Gulf War Illness
Jackie Zhu et al.
International Journal of Environmental Research and Public Health (2020)
Ingestion ofLactobacillus intestinalisandLactobacillus reutericauses depression- and anhedonia-like phenotypes in antibiotic-treated mice via the vagus nerve
Siming Wang et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos et al.
LANCET (2020)
Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression
Paulo R. Shiroma et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Antidepressant actions of ketamine engage cell-specific translation via eIF4E
Argel Aguilar-Valles et al.
NATURE (2020)
The role of dissociation in ketamine's antidepressant effects
Elizabeth D. Ballard et al.
NATURE COMMUNICATIONS (2020)
The stress susceptibility factor FKBP51 controls S-ketamine-evoked release of mBDNF in the prefrontal cortex of mice
Elmira Anderzhanova et al.
NEUROBIOLOGY OF STRESS (2020)
Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine
Yuko Fujita et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2020)
Antidepressant Drugs and Physical Activity: A Possible Synergism in the Treatment of Major Depression?
Claudia Savia Guerrera et al.
FRONTIERS IN PSYCHOLOGY (2020)
Is (S)-norketamine an alternative antidepressant for esketamine?
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
NMDAR-independent, cAMP-dependent antidepressant actions of ketamine
Nathan H. Wray et al.
MOLECULAR PSYCHIATRY (2019)
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
Allison C. Nugent et al.
MOLECULAR PSYCHIATRY (2019)
Ketamine: A Paradigm Shift for Depression Research and Treatment
John H. Krystal et al.
NEURON (2019)
Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective
Alvaro Lopez-Diaz et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
The role of short-chain fatty acids in microbiota-gut-brain communication
Boushra Dalile et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman et al.
NEURON (2019)
Depression researchers rethink mouse swim test
Sara Reardon
NATURE (2019)
Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
Lijia Chang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model
Zhongwei Xiong et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
(R)- and (S)-ketamine induce differential fMRI responses in conscious rats
Yukiko Masaki et al.
SYNAPSE (2019)
Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress
Kai Zhang et al.
TRANSLATIONAL PSYCHIATRY (2019)
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
Chun Yang et al.
TRANSLATIONAL PSYCHIATRY (2019)
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Todd D. Gould et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
An update on ketamine and its two enantiomers as rapid-acting antidepressants
Kai Zhang et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression
Alexandra D. Frolkis et al.
GUT (2019)
Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression
Niannian Huang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
Kenichi Fukumoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies
Cheng-Ta Li et al.
FRONTIERS IN PSYCHIATRY (2019)
5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
Kai Zhang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
Yukihiko Shirayama et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder
B. Kadriu et al.
MOLECULAR PSYCHIATRY (2018)
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Common Neurotransmission Recruited in (R,S)-Ketamine and (2R, 6R)-Hydroxynorketamine-Induced Sustained Antidepressant-like Effects
Thu Ha Pham et al.
BIOLOGICAL PSYCHIATRY (2018)
Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2018)
AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2018)
What Are the Causes for Discrepancies of Antidepressant Actions of (2R, 6R)-Hydroxynorketamine?
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2018)
Synthesis of Some Novel Thiadiazole Derivative Compounds and Screening Their Antidepressant-Like Activities
Nafiz Oncu Can et al.
MOLECULES (2018)
(2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray
Dylan Chou et al.
NEUROPHARMACOLOGY (2018)
(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
Jun-ichi Yamaguchi et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target
Filippo Caraci et al.
PHARMACOLOGICAL RESEARCH (2018)
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos et al.
PHARMACOLOGICAL REVIEWS (2018)
Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model
Kai Zhang et al.
SCIENTIFIC REPORTS (2018)
Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression
Yanling Zhou et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
Wei Zheng et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression
Yanling Zhou et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model
Kai Zhang et al.
PSYCHOPHARMACOLOGY (2018)
Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties
Bruk Getachew et al.
BMC MICROBIOLOGY (2018)
Is the History Repeated? Can (2R, 6R)-Hydroxynorketamine be Another Antidepressant?
Shigeyuki Chaki et al.
JOURNAL OF EXPERIMENTAL NEUROSCIENCE (2018)
Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression
Yukihiko Shirayama et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Considerations on the Off-label Use of Ketamine as a Treatment forMood Disorders
Samuel T. Wilkinson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Acute Amino Acid D-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms
I-Hua Wei et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine
Kenichi Fukumoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Targeting glutamate signalling in depression: progress and prospects
James W. Murrough et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
Tung-Ping Su et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model
Youge Qu et al.
SCIENTIFIC REPORTS (2017)
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Gerard Sanacora et al.
JAMA PSYCHIATRY (2017)
Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
Chun Yang et al.
TRANSLATIONAL PSYCHIATRY (2017)
Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis
B. Yang et al.
TRANSLATIONAL PSYCHIATRY (2017)
Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice
Chun Yang et al.
SCIENTIFIC REPORTS (2017)
High-Coverage Whole-Exome Sequencing Identifies Candidate Genes for Suicide in Victims with Major Depressive Disorder
Dora Tombacz et al.
SCIENTIFIC REPORTS (2017)
(R)-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2R,6R)-Hydroxynorketamine
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2017)
How do antidepressants work? New perspectives for refining future treatment approaches
Catherine J. Harmer et al.
LANCET PSYCHIATRY (2017)
Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression
Wen-Xue Liu et al.
PSYCHOPHARMACOLOGY (2016)
Detrimental Side Effects of Repeated Ketamine Infusions in the Brain
Kenji Hashimoto
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Post-Stroke Depression: A Review
Robert G. Robinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
Jaskaran B. Singh et al.
BIOLOGICAL PSYCHIATRY (2016)
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
Ji-chun Zhang et al.
CURRENT NEUROPHARMACOLOGY (2016)
Ketamine's antidepressant action: beyond NMDA receptor inhibition
Kenji Hashimoto
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
Bangkun Yang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy
Gavin Rush et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
G. B. Rogers et al.
MOLECULAR PSYCHIATRY (2016)
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
M-L Wong et al.
MOLECULAR PSYCHIATRY (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Detecting depression in Parkinson disease: A systematic review and meta-analysis
Zahra Goodarzi et al.
NEUROLOGY (2016)
BDNF - a key transducer of antidepressant effects
Carl Bjorkholm et al.
NEUROPHARMACOLOGY (2016)
Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
Chun Yang et al.
PSYCHIATRY RESEARCH (2016)
R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity
K. Hashimoto
PSYCHOLOGICAL MEDICINE (2016)
Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice
Wei Yao et al.
SCIENTIFIC REPORTS (2016)
Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study
K. Hashimoto et al.
TRANSLATIONAL PSYCHIATRY (2016)
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders
Y. Ohgi et al.
CURRENT MOLECULAR MEDICINE (2015)
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
C. Yang et al.
TRANSLATIONAL PSYCHIATRY (2015)
Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
Hiroyuki Koike et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Targeting of NMDA Receptors in the Treatment of Major Depression
Yong-Hui Dang et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
What is hydroxynorketamine and what can it bring to neurotherapeutics?
Nagendra S. Singh et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
Do the dissociative side effects of ketamine mediate its antidepressant effects?
David A. Luckenbaugh et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
Ji-chun Zhang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder A Randomized Clinical Trial
Adriana Feder et al.
JAMA PSYCHIATRY (2014)
The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
Kenji Hashimoto
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2014)
The Role of Eukaryotic Elongation Factor 2 Kinase in Rapid Antidepressant Action of Ketamine
Lisa M. Monteggia et al.
BIOLOGICAL PSYCHIATRY (2013)
Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)
Georges Mion et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
Elena Nosyreva et al.
JOURNAL OF NEUROSCIENCE (2013)
Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
Kenji Hashimoto
PROGRESS IN NEUROBIOLOGY (2013)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
The Neuroprotective Functions of Transforming Growth Factor Beta Proteins
Arpad Dobolyi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Mark J. Millan et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Roles of glutamate signaling in preclinical and/or mechanistic models of depression
Kenichi Tokita et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Phencyclidine/Schizophrenia: One View Toward the Past, The Other to the Future
Edward F. Domino et al.
SCHIZOPHRENIA BULLETIN (2012)
Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
Hiroyuki Koike et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression - No influence of celecoxib treatment
R. Musil et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
The Role of BDNF and Its Receptors in Depression and Antidepressant Drug Action: Reactivation of Developmental Plasticity
Eero Castren et al.
DEVELOPMENTAL NEUROBIOLOGY (2010)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
Kenji Hashimoto
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Emerging role of glutamate in the pathophysiology of major depressive disorder
Kenji Hashimoto
BRAIN RESEARCH REVIEWS (2009)
Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats
Leda S. B. Garcia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
Leda S. B. Garcia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Increased levels of glutamate in brains from patients with mood disorders
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Critical role of brain-derived neurotrophic factor in mood disorders
K Hashimoto et al.
BRAIN RESEARCH REVIEWS (2004)
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Y Shirayama et al.
JOURNAL OF NEUROSCIENCE (2002)
Transforming growth factor-β1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex
A Sometani et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
